Spiramycine is a macrolide antibiotic produced by the growth of certain strains of Streptomyces ambofaciens (Martindale 1999) . It is active on most gram-positive bacteria, on Meningococcus (pharyngeal forms), on Hoemophiles pertussis and Hoemophilus influenza (Middle East Medical Index 1988), on Mycoplasma pneumonial (Anon 1988) and Toxoplasma Gondii (Zaman 1975) .
Spiramycine is currently used for the treatment of pharyngitis, rhinopharyngitis, sinusitis, otitis, bronchitis, acute lung disease (Middle East Medical Index 1988) and respiratory tract infections (Bunnag et al. 1998) . It has also been used in the prevention and treatment of toxoplasmosis (Marcus 1983 , Martindale 1996 , 1999 . In this treatment, spiramycine is used for long periods of time, which may reach 3 weeks or more. Spiramycine have shown significant cure in gonorrhea (Anon 1970) .
Oral or parenteral formulations of spiramycine are used for the treatment and prophylaxis of local and systemic bacterial and mycoplasmal infections in animals and in some countries its ambonate salts are used as an additive in animal feeding stuff (FAO/WHO 1991) .
The present study was carried out to evaluate the possible genotoxic effect of spiramycine using chromosomal aberration analysis in somatic and germ cells and sperm abnormalities in male mice.
Materials and methods

Animals
Mature male white Swiss mice 9-12 weeks old, weighing 25-30 g were used in all experiments. The animals were obtained from a closed random-bred colony at the National Research Centre, maintained under controlled conditions of humidity and receiving food and water ad libitum.
Chemicals
Spiramycine (Rovamycine) is an antibiotic manufactured by Alexandria Pharmaceutical Co. Egypt under license of Rhome Poulenc Rorer, Paris, France.
Treatment and cytological preparations
Chromosomal aberrations: For bone-marrow or spermatocytes, groups of 5 animals were orally treated by gavage with repeated daily doses of 104, 208, 416 mg spiramycine kg-1 b.wt. These doses are equivalent to half, once and twice of the therapeutic dose respectively and are calculated according to the body relative surface area of man and mice as described by Paget and Barnes (1964) . Various concentrations of spiramycine were prepared by dissolving in gum acacia 10% on magnetic stirrer 30 min prior to administration via oral gavage. Gum acacia is used in medicine as a demulcent and as an emulsifying agent (Fahmy and Aly 1995) . In all doses samples were taken 8 and 24 h after the last treatment.
Bone-marrow chromosomes were prepared following the method of Yosida and Amano (1965) . Spermatocytes at diakinesis metaphase I were prepared according to the air drying technique of Evans et al. (1964) . Slides were stained with 7% Giemsa in phosphate buffer (pH 6.8). At least 75-100 well spread metaphases were analyzed per each animal scoring different types of aberrations.
Mitotic activity: The effect of spiramycine on the mitotic activity of bone-marrow cells was investigated. For each mouse, 1000 cells were analyzed. Dividing cells were recorded and the mitotic indices were calculated (number of dividing cells/1000 cells).
Sperm-shape abnormalities: Groups of animals (5/group) were orally treated by gavage for 5 consecutive days with spiramycine at the dose levels of 104, 208, 416 mg kg-1 b.wt./day. Animals were killed by cervical dislocation 35 d after administering the first dose. Sperms were prepared according to the recommended method of Wyrobek and Bruce (1978) . The epididymides excised and minced in 2 ml physiological saline, dispersed and filtered to exclude large tissue fragments. Smears were prepared and stained with 1% Eosin Y. One thousand sperms were counted for each animal scoring different types of sperm abnormalities (head-tail).
For all the above experiments, control groups (non-treated and vehicle) were run alongside the test material.
Statistical analysis
For chromosomal aberrations and sperm abnormalities, the significance of the experimental versus control data was calculated using t-test.
The results of mitotic index were statistically analyzed using F-test (Sendecore and Cochran 1980) .
Results
Bone-marrow chromosomes Imai et al. (1981) and Hu and Zhu (1990 son et al. 1984) and in mice (Devi and Reddy 1985, Lavu et al. 1985 ).
In conclusion, spiramycine induced some clastogenic effect in the mice examined.
